Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor

scientific article published on 01 April 2000

Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0968-0896(00)00016-X
P698PubMed publication ID10819167

P2093author name stringS H Kim
J A Katzenellenbogen
P2860cites workNonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenesQ68417319
Bis (p-acetoxyphenyl) cyclohexylidenemethane(F6066), a non-steroidal compound with pronounced effects on the reproductive systemQ72750203
New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligandsQ73183280
EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors alpha and betaQ74013231
Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: limitations to the interpretation of experiments characterizing the activity of individual isomersQ93579746
Molecular basis of agonism and antagonism in the oestrogen receptorQ27746278
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifenQ27766417
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyQ28283241
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and betaQ28304508
Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (.+-.)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]-1,2-propanediol and characterization and synthesis of a biologically important metaboliteQ28329199
Rapid chromatographic technique for preparative separations with moderate resolutionQ29391396
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding siteQ34419702
The future of new pure antiestrogens in clinical breast cancerQ40920558
Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responsesQ41112992
2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenesQ42214458
1,2-bis(4-Hydroxyphenyl)-3,4-dihydro-6-hydroxynaphthalene, a photofluorogenic ligand for the estrogen receptorQ42220794
1,2-Diaryl-3,4-dihydronaphthalenes: photofluorogenic ligands for the estrogen receptorQ42230288
Comparative QSAR analysis of estrogen receptor ligandsQ46485077
Antiestrogenic action of raloxifene and tamoxifen: today and tomorrowQ47842230
Photoaffinity labels for estrogen binding proteins of rat uterusQ47954177
1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assaysQ48001030
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.Q52552041
Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.Q53962333
A one-step alternative to the Grignard reactionQ56611053
11.beta.-Methoxy-, 11.beta.-ethyl, and 17.alpha.-ethynyl-substituted 16.alpha.-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivityQ67677251
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)785-793
P577publication date2000-04-01
P1433published inBioorganic & Medicinal ChemistryQ2904200
P1476titleTriarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor
P478volume8

Reverse relations

cites work (P2860)
Q52025325A validation study on the practical use of automated de novo design.
Q34109712Application of the McMurry coupling reaction in the synthesis of tri- and tetra-arylethylene analogues as potential cancer chemotherapeutic agents
Q42438081De novo design, synthesis and evaluation of a non-steroidal diphenylnaphthyl propylene ligand for the estrogen receptor
Q34466243Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities
Q41829975Effect of the amino chain length and the transformation into citric acid salts of aryl-diphenyl-butenes and ferrocenyl-diphenyl-butenes bearing two dimethylaminoalkyl chains on their antimicrobial activities.
Q36781304Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor